Recently, a team of Israeli researchers developed a revolutionary treatment against a type of blood cancer.
The discovery involves a chemical that can refocus the immune response in people with multiple myeloma, a blood malignancy that affects plasma cells that produce antibodies.
Dr. Cyrille Cohen, one of the lead researchers, discusses his discovery and explains how effective the treatment is.
